Affect raises a seed round to grow its stimulant abuse recovery service – TechCrunch

Alex Wilhelm at TechCrunch took note when we secured our seed round funding to begin building our app to treat meth and cocaine addiction.

Alex, who is in recovery himself from alcohol use disorder, bluntly put it:

“The only good amount of meth usage is precisely and exactly zero meth usage. So what Affect is building could actually change the world for stimulant addicts if it works.”

Read more from the article below:

There are any number of seed rounds that cross our desks every day, a never-ending march of enterprise software, consumer apps, games, hardware, biotech and sometimes even a space startup. But amid the regular flow of funding news, it’s still rare to come across a company raising money to take on addiction with software. So when Affect’s $1 million seed round from AlleyCorp came to my attention, I wanted to learn a bit more.

As someone who went to rehab for alcohol use disorder in what appeared to be a partially renovated middle school where the highest-tech thing that was in our group rooms were chairs, the idea of using software to help addicts reduce use and get their life back intrigued me.

Focused on stimulant abuse in particular, the startup wants to help people addicted to methamphetamine, for example, fully cease their use of the drug. Affect CEO Kristin Muhlner talked me through the company’s efforts during an interview. In short, the Affect app combines contingency management (rewards for positive behaviors) and cognitive behavioral therapy, or CBT (a form of therapy with known impact on addiction). Regarding the latter, Muhlner told TechCrunch during an interview that well-known recovery programs like AA or SMART Recovery also use forms of CBT in their approaches to helping addicts.

The article continues at TechCrunch